Clinical neurochemistry is a branch of neuroscience that focuses on the chemical processes and neurotransmitter systems within the nervous system, particularly as they relate to neurological and psychiatric disorders. Neurotransmitters are chemical messengers that transmit signals between neurons in the brain and play a critical role in regulating various physiological and psychological functions, including mood, cognition, behavior, and emotion. Clinical neurochemists study the synthesis, release, reuptake, and metabolism of neurotransmitters such as serotonin, dopamine, norepinephrine, glutamate, and gamma-aminobutyric acid (GABA). They also investigate how alterations in neurotransmitter systems contribute to the pathophysiology of neurological and psychiatric disorders, such as depression, anxiety, schizophrenia, bipolar disorder, Parkinson's disease, Alzheimer's disease, and substance use disorders. Clinical neurochemists use a variety of research methods and techniques, including biochemical assays, neuroimaging (e.g., PET, SPECT), pharmacological studies, and genetic analyses, to elucidate the neurochemical basis of these disorders. By understanding the neurochemical mechanisms underlying brain function and dysfunction, clinical neurochemists aim to develop new pharmacological treatments and interventions to alleviate symptoms, improve quality of life, and promote brain health.
Title : Scalp acupuncture with functional electrical stimulation for the treatment children with autism spectrum disorder
Zhenhuan Liu, Guangzhou University of Chinese Medicine, China
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy, Australia
Title : A structure-based strategy to target pathogenic α-synuclein in Parkinson’s disease
Salvador Ventura, Autonomous University of Barcelona, Spain
Title : Rabies: Challenges in taming the beast
Alan C Jackson, University of Calgary, Canada
Title : Designing and managing intelligent and ethical transformed health and social care ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Understanding Alzheimer's disease biomarkers across diverse populations - Opportunities and Insights for novel prevision medicine approaches
Sid O Bryant, Texas College of Osteopathic Medicine and University of North Texas Health Science Center Fort Worth, United States